GLAND Share Price Target 2040

CAGR-based price projection for Gland Pharma Limited (GLAND) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (26.0% CAGR)
Rs 73,119
2040 Target
Base Case (65.0% CAGR)
Rs 3,190,678
2040 Target
Bull Case (224.0% CAGR)
Rs 40,364,048,053
2040 Target

Current Market Snapshot

CMP: Rs 2,874.40
52W High: Rs 3,026.20
52W Low: Rs 1,713.50
1Y CAGR: 172.3%
3Y CAGR: 65.0%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 3,622 Rs 4,743 Rs 9,313
2028 Rs 4,564 Rs 7,827 Rs 30,172
2029 Rs 5,751 Rs 12,916 Rs 97,756
2030 Rs 7,246 Rs 21,313 Rs 316,720
2031 Rs 9,131 Rs 35,170 Rs 1,026,141
2032 Rs 11,505 Rs 58,035 Rs 3,324,597
2033 Rs 14,497 Rs 95,767 Rs 10,771,370
2034 Rs 18,268 Rs 158,030 Rs 34,898,192
2035 Rs 23,018 Rs 260,773 Rs 113,066,745
2036 Rs 29,004 Rs 430,316 Rs 366,325,250
2037 Rs 36,547 Rs 710,086 Rs 1,186,858,158
2038 Rs 46,052 Rs 1,171,750 Rs 3,845,304,928
2039 Rs 58,028 Rs 1,933,566 Rs 12,458,413,738
2040 Rs 73,119 Rs 3,190,678 Rs 40,364,048,053

Other GLAND Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the GLAND share price target for 2040?

Based on historical growth analysis, the GLAND share price target for 2040 ranges from Rs 73,119 (conservative) to Rs 3,190,678 (base case) to Rs 40,364,048,053 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of GLAND?

The current market price of GLAND (Gland Pharma Limited) is Rs 2,874.40. The 52-week high is Rs 3,026.20 and 52-week low is Rs 1,713.50.

Is GLAND a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for GLAND price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 26.0% CAGR), Base (65.0% CAGR), and Bull (optimistic at 224.0% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.